RESUMEN
Coenzyme Q (CoQ) is a redox lipid that fulfills critical functions in cellular bioenergetics and homeostasis. CoQ is synthesized by a multi-step pathway that involves several COQ proteins. Two steps of the eukaryotic pathway, the decarboxylation and hydroxylation of position C1, have remained uncharacterized. Here, we provide evidence that these two reactions occur in a single oxidative decarboxylation step catalyzed by COQ4. We demonstrate that COQ4 complements an Escherichia coli strain deficient for C1 decarboxylation and hydroxylation and that COQ4 displays oxidative decarboxylation activity in the non-CoQ producer Corynebacterium glutamicum. Overall, our results substantiate that COQ4 contributes to CoQ biosynthesis, not only via its previously proposed structural role but also via the oxidative decarboxylation of CoQ precursors. These findings fill a major gap in the knowledge of eukaryotic CoQ biosynthesis and shed light on the pathophysiology of human primary CoQ deficiency due to COQ4 mutations.
Asunto(s)
Células Eucariotas , Ubiquinona , Humanos , Descarboxilación , Células Eucariotas/metabolismo , Oxidación-Reducción , Escherichia coli/genética , Escherichia coli/metabolismo , Estrés Oxidativo , Proteínas Mitocondriales/metabolismoRESUMEN
Using a set of conformationally restricted Proline-derived Modules (ProMs), our group has recently succeeded in developing inhibitors for the enabled/vasodilator-stimulated phosphoprotein homologyâ 1 (EVH1) domain, which is a key mediator of cell migration and plays an important role in tumor metastasis. While these (formally) pentapeptidic compounds show nanomolecular binding affinities towards EVH1, their drug-like properties and cell permeability need to be further optimized before they can be clinically tested as therapeutic agents against metastasis. In this study, we sought to improve these properties by removing the C-terminal carboxylic acid function of our peptoids, either by late-stage decarboxylation or by direct synthesis. For late-stage decarboxylation of ProM-like systems, a method for reductive halo decarboxylation was optimized and applied to several proline-derived substrates. In this way, a series of new decarboxy ProMs suitable as building blocks for decarboxy EVH1 inhibitors were obtained. In addition, we incorporated decarboxy-ProM-1 into the pentapeptide-like compound Ac[2ClF][ProM-2][Decarb-ProM-1], which showed similar affinity towards EVH1 as the methyl ester derivative (Ac[2Cl-F][ProM-2][ProM1]OMe). However, despite better calculated drug-like properties, this compound did not inhibit chemotaxis in a cellular assay.
Asunto(s)
Péptidos , Prolina , Prolina/química , Descarboxilación , Péptidos/química , Péptidos/farmacología , Humanos , Unión ProteicaRESUMEN
Baloxavir marboxil (1; BXM) is a potent drug used for treating influenza infections. The current synthetic route to BXM (1) is based on optical resolution; however, this method results in the loss of nearly 50% of the material. This study aimed to describe an efficient and simpler method for the synthesis of BXM. We achieved a stereoselective synthesis of BXM (1). The tricyclic triazinanone core possessing a chiral center was prepared via diastereoselective cyclization utilizing the readily available amino acid l-serine. The carboxyl moiety derived from l-serine was removed via photoredox decarboxylation under mild conditions to furnish the chiral tricyclic triazinanone core ((R)-14). The synthetic route demonstrated herein provides an efficient and atomically economical method for preparing this potent anti-influenza agent.
Asunto(s)
Dibenzotiepinas , Serina , Estereoisomerismo , Ciclización , Serina/química , Estructura Molecular , Dibenzotiepinas/química , Dibenzotiepinas/síntesis química , Triazinas/química , Triazinas/síntesis química , Oxidación-Reducción , Descarboxilación , Morfolinas/química , Morfolinas/síntesis química , Piridonas/química , Piridonas/síntesis química , Procesos Fotoquímicos , Antivirales/síntesis química , Antivirales/químicaRESUMEN
Oxaloacetic acid (OAA) is a ß-ketocarboxylic acid, which plays an important role as an intermediate in some metabolic pathways, including the tricarboxylic acid cycle, gluconeogenesis and fatty acid biosynthesis. Animal studies have indicated that supplementing oxaloacetic acid shows an increase of lifespan and other substantial health benefits including mitochondrial DNA protection, and protection of retinal, neural and pancreatic tissues. Most of the chemical transformations of OAA in the metabolic pathways have been extensively studied; however, the understanding of decarboxylation of OAA at the atomic level is relatively lacking. Here, we carried out MD simulations and combined quantum mechanical/molecular mechanical (QM/MM) calculations as an example to systematically elucidate the binding modes, keto-enol tautomerization and decarboxylation of OAA in the active site of macrophomate synthase (MPS), which is a Mg(II)-dependent bifunctional enzyme that catalyzes both the decarboxylation of OAA and [4+2] cycloaddition of 2-pyrone with the decarboxylated intermediate of OAA (pyruvate enolate). On the basis of our calculations, it was found that the Mg2+-coordinated oxaloacetate may exist in enol forms and keto forms. The four keto forms can be transformed into each other by simply rotating the C2-C3 single bond, nevertheless, the keto-enol tautomerization strictly requires the assistance of pocket water molecules. In addition, the decarboxylation is stereo-electronically controlled, i.e., it is the relative orientation of the terminal carboxyl anion that determines the rate of decarboxylation. As such, the chemistry of oxaloacetate in the active site of MPS is complex. On one hand, the most stable binding mode (K-I) may undergo enol-keto tautomerization to isomerize to the enol form, which may further react with the second substrate; on the other hand, K-I may isomerize to another binding mode K-II to proceed decarboxylation to generate pyruvate enolate and CO2. Starting from K-I, the enol-keto tautomerization corresponds to a barrier of 16.2 kcal mol-1, whereas the decarboxylation is associated with an overall barrier of 19.7 kcal mol-1. These findings may provide useful information for understanding the chemistry of OAA and the catalysis of related enzymes, and they are basically in agreement with the available experimental kinetic data.
Asunto(s)
Ascomicetos , Complejos Multienzimáticos , Dominio Catalítico , Descarboxilación , Simulación de Dinámica Molecular , Ácido Oxaloacético/metabolismo , Ácido Oxaloacético/química , Teoría Cuántica , Estereoisomerismo , Complejos Multienzimáticos/química , Ascomicetos/enzimologíaRESUMEN
Many organic reactions rely on CO2 sources to generate important structural units and valuable chemicals. In this study, we compared the effects of cannabidiol (CBD) and cannabidiolic acid (CBDA) on the supercritical CO2 (scCO2)-induced de/carboxylation reaction. The results showed that CBD was directly carboxylated in the ortho-position to form CBDA with up to 62% conversion. Meanwhile, CBDA decarboxylation occurred on hemp plant material via varying composition. Mechanistic studies revealed that CBD carboxylation was influenced not only by the physical properties of scCO2, but also by the vegetable matrix.
Asunto(s)
Cannabidiol , Cannabinoides , Cannabis , Dióxido de Carbono , Cannabidiol/química , Cannabis/química , Cannabinoides/química , Dióxido de Carbono/química , Estructura Molecular , DescarboxilaciónRESUMEN
The development of selective extraction protocols for Cannabis-inflorescence constituents is still a significant challenge. The characteristic Cannabis fragrance can be mainly ascribed to monoterpenes, sesquiterpenes and oxygenated terpenoids. This work investigates the entrapment of Cannabis terpenes in olive oil from inflorescences via stripping under mild vacuum during the rapid microwave-assisted decarboxylation of cannabinoids (MW, 120 °C, 30 min) and after subsequent extraction of cannabinoids (60 and 100 °C). The profiles of the volatiles collected in the oil samples before and after the extraction step were evaluated using static headspace solid-phase microextraction (HS-SPME), followed by gas chromatography coupled to mass spectrometry (GC-MS). Between the three fractions obtained, the first shows the highest volatile content (~37,400 mg/kg oil), with α-pinene, ß-pinene, ß-myrcene, limonene and trans-ß-caryophyllene as the main components. The MW-assisted extraction at 60 and 100 °C of inflorescences using the collected oil fractions allowed an increase of 70% and 86% of total terpene content, respectively. Considering the initial terpene amount of 91,324.7 ± 2774.4 mg/kg dry inflorescences, the percentage of recovery after decarboxylation was close to 58% (mainly monoterpenes), while it reached nearly 100% (including sesquiterpenes) after extraction. The selective and efficient extraction of volatile compounds, while avoiding direct contact between the matrix and extraction solvents, paves the way for specific applications in various aromatic plants. In this context, aromatized extracts can be employed to create innovative Cannabis-based products within the hemp processing industry, as well as in perfumery, cosmetics, dietary supplements, food, and the pharmaceutical industry.
Asunto(s)
Cannabinoides , Cannabis , Alucinógenos , Sesquiterpenos Policíclicos , Sesquiterpenos , Terpenos/química , Cannabinoides/química , Cannabis/química , Aceite de Oliva , Descarboxilación , Microondas , Monoterpenos/química , Sesquiterpenos/química , Agonistas de Receptores de CannabinoidesRESUMEN
The malic enzyme (ME) catalyzes the synthesis of L-malic acid (L-MA) from pyruvic acid and CO2 with NADH as the reverse reaction of L-MA decarboxylation. Carboxylation requires excess pyruvic acid, limiting its application. In this study, it was determined that CO2 was the carboxyl donor by parsing the effects of HCO3- and CO2, which provided a basis for improving the L-MA yield. Moreover, the concentration ratio of pyruvic acid to NADH was reduced from 70:1 to 5:1 using CO2 to inhibit decarboxylation and to introduce the ME mutant A464S with a 2-fold lower Km than that of the wild type. Finally, carboxylation was coupled with NADH regeneration, resulting in a maximum L-MA yield of 77 % based on the initial concentration of pyruvic acid. Strategic modifications, including optimal reactant ratios and efficient mutant ME, significantly enhanced L-MA synthesis from CO2, providing a promising approach to the biotransformation process.
Asunto(s)
Biocatálisis , Dióxido de Carbono , Malato Deshidrogenasa , Malatos , Ácido Pirúvico , Malatos/metabolismo , Dióxido de Carbono/metabolismo , Malato Deshidrogenasa/metabolismo , Ácido Pirúvico/metabolismo , NAD/metabolismo , Descarboxilación , Cinética , MutaciónRESUMEN
Studies with secretory cavity contents and air-dried inflorescence extracts of the CBD-rich hemp strain, Cannabis sativa cv. 'Cherry Wine', were conducted to compare the decarboxylation rates of acidic cannabinoids between two groups. The secretory cavity contents acquired from the capitate-stalked glandular trichomes by glass microcapillaries, and inflorescence samples air-dried for 15 days of storage in darkness at room temperature were analysed by high-pressure liquid chromatography. The ratio of acidic cannabinoids to the total cannabinoids was ranging from 0.5% to 2.4% lower in the air-dried inflorescence samples compared to the secretory cavity samples as follows. In the secretory cavity content, the percentage of acidic cannabinoids to the total cannabinoids was measured as 86.4% cannabidiolic acid (CBDA), 6.5% tetrahydrocannabinolic acid (THCA), 4.3% cannabichromenic acid (CBCA), 1.4% cannabigerolic acid (CBGA), and 0.6% cannabidivarinic acid (CBDVA), respectively. In the air-dried inflorescence, however, the acidic cannabinoids were detected with 84% CBDA, 4.8% THCA, 3.3% CBCA, 0.8% CBGA, and 0.3% Δ9-tetrahydrocannabivarinic acid (Δ9-THCVA), respectively. The ratio of cannabidiol (CBD) to cannabidiolic acid (CBDA) was close to 1:99 (w/w) in secretory cavity contents, however, it was roughly 1:20 (w/w) in the air-dried inflorescence. In addition, Δ9-tetrahydrocannabivarin (Δ9-THCV) and Δ9-tetrahydrocannabivarinic acid (Δ9-THCVA) were only detected in the air-dried inflorescence sample, and the ratio of Δ9-THCV to Δ9-THCVA was about 1:20 (w/w). Besides, cannabidivarinic acid (CBDVA) was only observed in the secretory cavity content.
Asunto(s)
Cannabinoides , Cannabis , Inflorescencia , Cannabis/química , Cannabinoides/análisis , Inflorescencia/química , Descarboxilación , Extractos Vegetales/química , Extractos Vegetales/análisis , Cromatografía Líquida de Alta PresiónRESUMEN
iso-Orotate decarboxylase (IDCase), which is involved in the thymidine salvage pathway, has attracted considerable interest owing to its chemical similarity to a hypothetical DNA decarboxylase in mammals. Although valuable insights into the active DNA demethylation of 5-methyl-cytosine can be obtained from the decarboxylation mechanism of 5-carboxyl-uracil (5caU) catalyzed by IDCase, this mechanism remains under debate. In this study, the catalytic mechanism of 5caU decarboxylation by IDCase was studied using hybrid quantum mechanics/molecular mechanics (QM/MM) methodologies and density functional theory (DFT) calculations with a truncated model. The calculations supported a mechanism involving three sequential stages: activation of the 5caU substrate via proton transfer from an arginine (R262') to the carboxyl group of 5caU, formation of a tetrahedral intermediate, and decarboxylation of the tetrahedral intermediate to generate uracil as the product. The reaction pathways and structures obtained using the QM/MM and DFT methods coincided with each other. These simulations provided detailed insights into the unique mechanism of IDCase, clarifying various unresolved issues, such as the critical role of R262'. In addition, aspartate D323 was found to act as a general base in the tetrahedral intermediate formation step and a general acid in the later C-C bond cleavage step.
Asunto(s)
Teoría Funcional de la Densidad , Descarboxilación , Simulación de Dinámica Molecular , Teoría Cuántica , Carboxiliasas/química , Carboxiliasas/metabolismo , Biocatálisis , Orotidina-5'-Fosfato Descarboxilasa/química , Orotidina-5'-Fosfato Descarboxilasa/metabolismo , Uracilo/química , Uracilo/metabolismoRESUMEN
La tricomonosis urogenital humana, causada por el parásito Trichomonas vaginalis, es una de las infecciones de transmisión sexual (I.T.S.) de mayor prevalencia en el mundo, con un total de 276 millones de casos cada año, según la OMS. Algunos autores la han calificado como una enfermedad desatendida u olvidada ligada a la pobreza, a pesar de que más del 50% de las I.T.S. curables se deben a este agente etiológico. La tricomonosis cursa con un rango amplio de manifestaciones clínicas, que van desde casos asintomáticos hasta cuadros más graves e invasivos de los conductos genitourinarios. Se ha relacionado la infección con el riesgo de adquisición y transmisión del VIH y de lesiones preneoplásicas de cérvix y próstata. Este protozoo parásito presenta una gran variabilidad intraespecífica en su comportamiento patogénico, probablemente por el tamaño y complejidad de su genoma, con más de 60.000 genes codificantes. Es capaz de sobrevivir y colonizar un nicho complejo sometido a constantes fluctuaciones, el aparato genitourinario, pasando desapercibido en muchos casos. El tamaño y complejidad de su genoma convierten a T. vaginalis en un parásito de gran interés científico para el estudio de los mecanismos de patogenia y evasión de la respuesta inmune (AU)
Trichomonosis is one of the most prevalent nonviral sexually transmitted infection (S.T.I.) worldwide, with an estimated 276 million cases per year according to WHO overview. Little attention is paid to this disease, although more than 50% of S.T.I. curable are caused by this protozoon. Clinically, Trichomonas vaginalis infection can produce a wide range of pathological manifestations, from asymptomatic presentation to severe inflammatory and invasive lesions in the genitourinary tract of both men and women. The possible role displayed by T. vaginalis as a viral vector might also explain its role as a risk factor in the development of cervical and prostate neoplasia. In addition, trichomonosis is strongly associated with transmission and acquisition of other bacterial and viral pathogens like HIV. T. vaginalis is a very complex organism and has developed diverse mechanisms for the colonization of the genitourinary tract probably due to its extensive genome. This parasite must survive in a hostile environment exposed to continue fluctuations. Surprisingly, T. vaginalis possesses one of the largest and most repetitive genomes, with a core set of 60,000 protein-coding genes. According to all these features, T. vaginalis could be considered an excellent model of parasite to be studied in order to better understand the dynamics and immune evasion mechanisms of such versatile parasite (AU)
Asunto(s)
Humanos , Masculino , Femenino , Trichomonas vaginalis/aislamiento & purificación , Enfermedades de Transmisión Sexual/tratamiento farmacológico , Enfermedades de Transmisión Sexual/epidemiología , Infecciones por VIH/complicaciones , Infecciones por VIH/transmisión , Glucólisis , Descarboxilación , Metronidazol/uso terapéutico , Trichomonas vaginalis/citología , Trichomonas vaginalis/patogenicidad , Técnicas de Genotipaje , Sensibilidad y Especificidad , Factores de RiesgoRESUMEN
El esqueleto es uno de los sistemas más grandes de un vertebrado y, como tal, es razonable especular que no puede funcionar aislado del resto del organismo. De hecho, sabemos que existen sistemas complejos de regulación cruzada entre el esqueleto y muchos otros órganos. Hoy poseemos herramientas que nos permiten realizar supresión genética en células o tejidos específicos. Esto nos ha permitido comprender cómo los órganos se comunican entre sí y ha revitalizado el concepto de fisiología del organismo como un todo. Efectivamente, los últimos años han sido testigos del descubrimiento de funciones inesperadas que ejerce el esqueleto y que afectan al organismo en su totalidad. Una de tales funciones reconocidas recientemente es el control del metabolismo energético, a través de la secreción de osteocalcina. La osteocalcina es una hormona producida por los osteoblastos que regula la secreción de insulina, la sensibilidad a esta hormona y el metabolismo energético. Los hallazgos iniciales suscitaron varias preguntas fundamentales sobre la naturaleza de la acción de la insulina sobre el hueso. Pero esto solo fue la punta del iceberg. Efectivamente, más adelante se descubrió, mediante el análisis de ratones que carecen del receptor de insulina (Ins R) solamente en osteoblastos, que la acción de la insulina sobre estas células favorecía la homeostasis de la glucosa en todo el cuerpo. Es importante destacar que esta función de la insulina en los osteoblastos opera mediante la regulación negativa de la carboxilación y la biodisponibilidad de la osteocalcina. Más aún, se observó que las vías de señalización de la insulina en los osteoblastos regulan positivamente no solo la formación sino también la resorción del hueso. Curiosamente, parece que las vías de señalización de la insulina en osteoblastos pueden inducir la activación de la osteocalcina mediante la estimulación de la actividad de los osteoclastos. De hecho, el bajo pH generado durante la resorción ósea es suficiente para desencadenar la descarboxilación (y subsiguiente activación) de la osteocalcina. En breve discutiremos dos nuevas proposiciones: 1) los osteoblastos son un blanco utilizado por la insulina para controlar la homeostasis de la glucosa en todo el organismo y 2) la resorción ósea desempeña un papel fundamental en la regulación de la activación de la osteocalcina. (AU)
The skeleton is one of the biggest systems in a vertebrate animal and, as such, it is reasonable to speculate that it cannot function isolated from the rest of the organism. In fact, we know that complex systems exist for the cross-regulation between the skeleton and several other organs. Today, we have the tools that allow us to perform genetic suppression in specific cells or tissues. This has allow us understand the mechanisms by which the organs communicate with each other and has revitalized the concept of organismal physiology as a whole. Studies conducted in recent years have uncovered unexpected functions performed by the skeleton. One of these is the control of global energy metabolism, through the secretion of osteocalcin, a protein produced by osteoblasts that acts as a hormone regulating insulin secretion, insulin sensitivity and energy expenditure. The evidence comes from the analysis of mice lacking insulin receptor (InsR) exclusively in osteoblasts. These mice have a global metabolic phenotype demonstrating that the action of insulin in osteoblasts promotes the homeostasis of glucose throughout the body. This action of insulin in osteoblasts is mediated by the negative regulation of the carboxylation (and bioavailability) of osteocalcin. The decarboxylation (and activation) of osteocalcin, in turn, occurs in the osteoclastic resorption pit. Briefly: the osteoblast is a target used by insulin to control the homeostasis of glucose throughout the body and bone resorption is the mechanism that regulates the activation of osteocalcin. (AU)
Asunto(s)
Humanos , Animales , Ratones , Osteocalcina/biosíntesis , Metabolismo Energético , Insulina/biosíntesis , Osteoblastos/metabolismo , Osteogénesis , Esqueleto/fisiología , Esqueleto/metabolismo , Resorción Ósea/metabolismo , Receptor de Insulina/metabolismo , Transducción de Señal , Osteocalcina/metabolismo , Descarboxilación , Secreción de Insulina , Glucosa/biosíntesis , Glucosa/metabolismo , Insulina/metabolismoRESUMEN
Neuronal senescence caused by diabetic neuropathy is considered a common complication of diabetes mellitus. Neuronal senescence leads to the secretion of pro-inflammatory cytokines, the production of reactive oxygen species, and the alteration of cellular homeostasis. Agmatine, which is biosynthesized by arginine decarboxylation, has been reported in previous in vitro to exert a protective effect against various stresses. In present study, agmatine attenuated the cell death and the expression of pro-inflammatory cytokines such as IL-6, TNF-alpha and CCL2 in high glucose in vitro conditions. Moreover, the senescence associated-beta-galatosidase's activity in high glucose exposed neuronal cells was reduced by agmatine. Increased p21 and reduced p53 in high glucose conditioned cells were changed by agmatine. Ultimately, agmatine inhibits the neuronal cell senescence through the activation of p53 and the inhibition of p21. Here, we propose that agmatine may ameliorate neuronal cell senescence in hyperglycemia.
Asunto(s)
Envejecimiento , Agmatina , Arginina , Senescencia Celular , Muerte Celular , Citocinas , Descarboxilación , Diabetes Mellitus , Neuropatías Diabéticas , Glucosa , Homeostasis , Hiperglucemia , Interleucina-6 , Neuronas , Especies Reactivas de Oxígeno , Factor de Necrosis Tumoral alfaRESUMEN
Quinolones and fluoroquinolones are widely used to treat uropathogenic
Asunto(s)
Humanos , Farmacorresistencia Bacteriana Múltiple/genética , Infecciones por Escherichia coli/tratamiento farmacológico , Fluoroquinolonas/uso terapéutico , Lactosa/metabolismo , Ácido Nalidíxico/uso terapéutico , Ornitina Descarboxilasa/genética , Infecciones Urinarias/tratamiento farmacológico , Escherichia coli Uropatógena/genética , Antibacterianos/uso terapéutico , Brasil , Girasa de ADN/genética , Topoisomerasa de ADN IV/genética , Descarboxilación/genética , Descarboxilación/fisiología , Infecciones por Escherichia coli/microbiología , Pruebas de Sensibilidad Microbiana , Ornitina/metabolismo , Infecciones Urinarias/microbiología , Escherichia coli Uropatógena/efectos de los fármacos , Escherichia coli Uropatógena/enzimología , Escherichia coli Uropatógena/aislamiento & purificaciónRESUMEN
BACKGROUND: Isocitrate dehydrogenase (IDH) catalyzes the oxidative decarboxylation of isocitrate to yield alpha-ketoglutarate (alpha-KG) with production of reduced nicotinamide adenine dinucleotide (NADH). Dysfunctional IDH leads to reduced production of alpha-KG and NADH and increased production of 2-hydroxyglutarate, an oncometabolite. This results in increased oxidative damage and stabilization of hypoxia-inducible factor alpha, causing cells to be prone to tumorigenesis. METHODS: This study investigated IDH mutations in 61 Ewing sarcoma family tumors (ESFTs), using a pentose nucleic acid clamping method and direct sequencing. RESULTS: We identified four cases of ESFTs harboring IDH mutations. The number of IDH1 and IDH2 mutations was equal and the subtype of IDH mutations was variable. Clinicopathologic analysis according to IDH mutation status did not reveal significant results. CONCLUSIONS: This study is the first to report IDH mutations in ESFTs. The results indicate that ESFTs can harbor IDH mutations in previously known hot-spot regions, although their incidence is rare. Further validation with a larger case-based study would establish more reliable and significant data on prevalence rate and the biological significance of IDH mutations in ESFTs.
Asunto(s)
Humanos , Carcinogénesis , Constricción , Descarboxilación , Incidencia , Isocitrato Deshidrogenasa , NAD , Prevalencia , Sarcoma de EwingRESUMEN
Impaired glucose homeostasis is one of the risk factors for causing metabolic diseases including obesity, type 2 diabetes, and cancers. In glucose metabolism, pyruvate dehydrogenase complex (PDC) mediates a major regulatory step, an irreversible reaction of oxidative decarboxylation of pyruvate to acetyl-CoA. Tight control of PDC is critical because it plays a key role in glucose disposal. PDC activity is tightly regulated using phosphorylation by pyruvate dehydrogenase kinases (PDK1 to 4) and pyruvate dehydrogenase phosphatases (PDP1 and 2). PDKs and PDPs exhibit unique tissue expression patterns, kinetic properties, and sensitivities to regulatory molecules. During the last decades, the up-regulation of PDKs has been observed in the tissues of patients and mammals with metabolic diseases, which suggests that the inhibition of these kinases may have beneficial effects for treating metabolic diseases. This review summarizes the recent advances in the role of specific PDK isoenzymes on the induction of metabolic diseases and describes the effects of PDK inhibition on the prevention of metabolic diseases using pharmacological inhibitors. Based on these reports, PDK isoenzymes are strong therapeutic targets for preventing and treating metabolic diseases.
Asunto(s)
Humanos , Acetilcoenzima A , Descarboxilación , Diabetes Mellitus Tipo 2 , Glucosa , Homeostasis , Isoenzimas , Mamíferos , Enfermedades Metabólicas , Metabolismo , Obesidad , Oxidorreductasas , Monoéster Fosfórico Hidrolasas , Fosforilación , Fosfotransferasas , Complejo Piruvato Deshidrogenasa , Ácido Pirúvico , Factores de Riesgo , Regulación hacia ArribaRESUMEN
Antecedentes: En la industria de alimentos es cada vez más común la utilización de aditivos naturales capaces de reemplazar los aditivos químicos, esto es debido a la tendencia a consumir alimentos más naturales y saludables. En la naturaleza existen diferentes compuestos que pueden cumplir dicha función, como el caso de los propóleos obtenidos en las colmenas de las abejas melíferas que presentan compuestos bioactivos con capacidad antimicrobiana y antioxidante y, por tanto, podría presentarse como una alternativa a la utilización de nitritos en productos cárnicos. Objetivo: Valorar la actividad antimicrobiana in-vitro del extracto etanólico de propóleos (EEP) sobre ciertas bacterias patógenas y su influencia en las características fisicoquímicas y sensoriales de chorizos. Métodos: Se realizó la extracción de los propóleos con alcohol etanólico al 96% y se determinó su actividad antimicrobiana in vitro sobre S. aureus, Salmonella spp., E. coli y Clostridium spp. Se prepararon chorizos de acuerdo a los siguientes tratamientos: (1) EEP 0.8mg/mL; (2) 0,2g/Kg de nitrito de sodio y eritorbato de sodio; (3) alcohol 96% (control) y se realizaron los análisis fisicoquímicos correspondientes a la determinación de ácido tiobarbitúrico (TBA) y bases volátiles de nitrógeno (BVT-N) y pruebas sensoriales cada ocho días durante cuatro semanas. Se realizó análisis de varianza de dos vías y prueba de Tukey, el nivel de significancia fue de p<0,05). Se observaron diferencias significativas (p<0,05) en los valores de TBA. Conclusiones: El EEP al 0,8% presenta actividad antimicrobiana para los microorganismos patógenos evaluados. Adicionalmente, las características fisicoquímicas y sensoriales del producto no difieren de los chorizos elaborados con nitrito
Asunto(s)
Humanos , Interacciones Microbianas , Técnicas In Vitro , Descarboxilación , AntiinfecciososRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Recién Nacido , Enfermedad de la Orina de Jarabe de Arce/genética , Convulsiones/etiología , Mutación , Descarboxilación , ElectroencefalografíaRESUMEN
Metabolic aberrations in the form of altered flux through key metabolic pathways are the major hallmarks of several life-threatening malignancies including malignant gliomas. These adaptations play an important role in the enhancement of the survival and proliferation of gliomas at the expense of the surrounding normal/healthy tissues. Recent studies in the field of neurooncology have directly targeted the altered metabolic pathways of malignant tumor cells for the development of anti-cancer drugs. Aerobic glycolysis due to elevated production of lactate from pyruvate regardless of oxygen availability is a common metabolic alteration in most malignancies. Aerobic glycolysis offers survival advantages in addition to generating substrates such as fatty acids, amino acids and nucleotides required for the rapid proliferation of cells. This review outlines the role of pyruvate dehydrogenase kinase (PDK) in gliomas as an inhibitor of pyruvate dehydrogenase that catalyzes the oxidative decarboxylation of pyruvate. An in-depth investigation on the key metabolic enzyme PDK may provide a novel therapeutic approach for the treatment of malignant gliomas.
Asunto(s)
Aminoácidos , Descarboxilación , Ácido Dicloroacético , Ácidos Grasos , Glioma , Glucólisis , Ácido Láctico , Redes y Vías Metabólicas , Nucleótidos , Oxidorreductasas , Oxígeno , Fosfotransferasas , Ácido PirúvicoRESUMEN
Redes neurales distribuidas en el encéfalo sustentan la generación de la vigilia y dos estados de sueño: sueño no REM y sueño REM. Estos tres estados comportamentales se engranan conjuntamente en una secuencia regular que constituye el ciclo vigilia-sueño. Este trabajo revisa y actualiza el conocimiento sobre la implicación del sistema histaminérgico en la organización del ciclo vigilia-sueño. Las neuronas histaminérgicas se localizan exclusivamente en el núcleo tuberomamilar hipotalámico, pero son el origen de proyecciones extensas a numerosas regiones encefálicas. Las neuronas histaminérgicas están activas durante la vigilia, especialmente con alta demanda atencional, y permanecen silentes en sueño no REM y sueño REM. Se han descrito cuatro receptores histaminérgicos metabotrópicos, de los cuales H1R, H2R y H3R están presentes en el sistema nervioso. H1R y H2R son fundamentalmente heterorreceptores postsinápticos, mientras que se piensa que H3R es mayormente un auto y heterorreceptor presináptico. Las neuronas histaminérgicas son activadas por las neuronas hipocretinérgicas y se cree que muchos de los efectos activadores de las hipocretinas se deben a acciones histaminérgicas. Las interacciones entre los axones histaminérgicos y los núcleos colinérgicos en el prosencéfalo y el troncoencéfalo son particularmente importantes para la activación cortical. Por el contrario, las neuronas histaminérgicas tuberomamilares, al igual que otras neuronas aminérgicas del locus coeruleus o del núcleo dorsal del rafe, son inhibidas por las neuronas del área preóptica promotoras de sueño no REM. Acciones inhibidoras adicionales sobre las neuronas histaminérgicas proceden de la liberación de adenosina en la región tuberomamilar. Finalmente, las neuronas histaminérgicas inhiben a las neuronas hipotalámicas REM-on que contienen hormona concentradora de melanina, apoyando así un papel permisivo del núcleo tuberomamilar en el sueño REM. De hecho, ratones deficientes para descarboxilasa de histidina, la enzima de síntesis de la histamina, muestran un aumento significativo de sueño REM (AU)
Distributed neural networks in the brain sustain generation of wakefulness and two sleep states: non-REM sleep and REM sleep. These three behavioral states are jointly ingrained in a rhythmic sequence that constitutes the sleepwakefulness cycle. This paper reviews and updates knowledge about the involvement of the histaminergic system in sleep-wakefulness cycle organization. Histaminergic neurons are exclusively located in the hypothalamic tuberomammillary nucleus, but are the source of a widespread projection system to many brain regions. Histamine neurons are active during waking, especially with high attention need, and remain silent in both non-REM and REM sleep. There have been described four metabotropic histamine receptors, of which H1R, H2R and H3R are present in the nervous system. H1R and H2R are mainly postsynaptic heteroreceptors, whereas H3R is thought to be mostly a presynaptic auto- and hetero-receptor. Histaminergic neurons are excited by hypocretinergic neurons and most of the arousing hypocretin effects are thought to depend on histaminergic actions. Interactions among histaminergic axons and cholinergic nuclei within forebrain and brainstem are particularly important for cortical activation. In contrast, histaminergic tuberomammillary neurons, similarly to other aminergic neurons in locus coeruleus or dorsal raphe nucleus, are inhibited by non-REM sleep-promoting neurons of the preoptic region. Further inhibitory actions on histamine neurons come from adenosine release on tuberomammillary region. Finally, histaminergic neurons inhibit REM-on hypothalamic neurons containing melanine-concentrating hormone, thus supporting a permissive role of tuberomammillary nucleus in REM sleep. Actually, knockout mice for histidine decarboxylase, the enzyme synthetizing histamine, show a significant REM sleep increase (AU)
Asunto(s)
Humanos , Masculino , Femenino , Trastornos del Sueño-Vigilia/tratamiento farmacológico , Promotores de la Vigilia/uso terapéutico , Receptores Histamínicos/uso terapéutico , Neuronas , Conducción Nerviosa , Privación de Sueño/tratamiento farmacológico , Neuronas Colinérgicas , Galanina/biosíntesis , DescarboxilaciónRESUMEN
Agmatine is a primary amine formed by decarboxylation of L-arginine synthesized in the mammalian brain. Recent studies have shown that agmatine is neuroprotective in models of trauma and ischemia. The purpose of this study was to evaluate the effect of agmatine on the expression of MMP2 and MMP9, which are expressed in reperfusion injury following cerebral ischemia. Mice were subjected to 2 h middle cerebral artery occlusion and 22 h reperfusion. Agmatine (100 mg/kg) was administered intraperitoneally at the start of reperfusion. Agmatine treatment significantly reduced the immunoreactivity of MMP2 and MMP9 in the cortex, striatum, and penumbra on the ipsilateral side. The immunoreactivity of MMP2 and MMP9 was markedly lower in blood vessels of the agmatine-treated group than in the experimental control group. Immunoblot analysis showed that agmatine treatment decreased the expression of MMP2 and MMP9. After exogenous agmatine administration, the expression of agmatine was higher in the striatum and penumbra of the agmatine-treated group than in the experimental control group. The fluorescence intensity was markedly greater in blood vessels in the agmatine-treated group than in the experimental control group. These data suggest that agmatine might decrease the expression of MMP2 and MMP9 by regulating NOS activity, and thereby modulating NO synthesis.